Article
High-Throughput Screening and Initial SAR Studies Identify a Novel Sub-micromolar Potent Human cGAS Inhibitor
2025-08-22
Abstract excerpt
Cyclic GMP-AMP synthase (cGAS) has emerged as a promising therapeutic target of several human diseases, including Alzheimer’s disease (AD) and other neurodegenerative disorders. As a cytosolic DNA sensor, cGAS generates an innate immune response to promote neuroinflammation by producing an endogenous agonist of the stimulator of interferon genes (STING), 2’3’-cyclic GMP-AMP (cGAMP), which activates the cGAS–STING...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 46863c39-13ca-5cf2-bb2d-cb26fb8d4cd9
- DOI
- 10.1101/2025.08.18.670979
